5 Best Small-Cap Humanoid Robotics Stocks — October 2026
Five small-cap humanoid robotics stocks ranked on our September 27, 2026 score snapshot: lidar, rapid prototyping, actuators and two deployed service-robot fleets, with the June-quarter filing behind each score.
Humanoid robotics moved in 2026 from demo videos to production planning, and the sell-side numbers moved with it. Goldman Sachs' Physical AI report (September 2026) raised its 2035 humanoid shipment forecast nearly fivefold to 6.5 million units, from roughly 1.4 million previously, and sized the 2035 market at $138 billion, with logistics and warehousing as the first scaled deployments and automotive manufacturing close behind. The public-market proof point came from China: Unitree priced its Shanghai STAR Market IPO in August 2026 at a valuation of about $9 billion and closed its August 19 debut up 460%, the first humanoid maker to list on the mainland. Tesla, meanwhile, is converting its former Model S/X line in Fremont to Optimus assembly, with management describing the early ramp as slow because the robot uses many new parts.
For a US small-cap investor the constraint is unchanged from our June 2026 list: our scored universe contains no humanoid pure-play. The exposure sits in the enabling layers — the lidar and camera stack that lets a robot perceive, the rapid prototyping of grippers, housings and gears, the actuators (motors, gearing, servo drives) that make up its joints, and the service robots already deployed in restaurants, hotels and on sidewalks. Below: five US-listed names ranked by our September 27, 2026 score snapshot. Three carry over from June (OUST, RR, SERV); Proto Labs and Allient are new. The October list leans toward component and manufacturing suppliers whose robotics revenue is visible in filings, and treats the two service-robot names as what they are: deployed fleets with unresolved economics. At the snapshot, four of the five sit under our $2 billion small-cap ceiling; Ouster, at $2.45 billion, has outgrown it.
Why the Small-Cap Humanoid Setup Is Different This Cycle
1. The investable layer is the bill of materials, not the robot. Goldman's $3,000 to $6,000 of semiconductor content per robot is a component-level figure, and components are where a US small-cap can sell into a humanoid program today. Ouster's lidar and camera sensors are what mobile and industrial robots, and the R&D platforms behind humanoids, use to see; Proto Labs machines, molds and prints the grippers, housings and gears that developers burn through on the way to a production design; Allient markets advanced actuation systems for humanoid robotics directly. Each of the three sells into other end markets first — data center, industrial automation, medical, aerospace — which is what makes the exposure fundable and also what dilutes it.
2. Robotics revenue has started to show up in filings, unevenly. Ouster called out warehouse automation and yard logistics as its Q2 drivers. In September 2026 Proto Labs disclosed that revenue from its robotics customers more than doubled in the first half of 2026 versus the first half of 2025, driven by robot developers moving from prototype toward commercial deployment. Allient's Medical segment grew 9% on surgical robotics, but humanoid robotics is a product category on its website, not a disclosed revenue line. The score cannot see any of it: the snapshot's trailing growth inputs read +52.5% for Ouster, +6.4% for Proto Labs and +4.6% for Allient, against June-quarter revenue growth of 56%, 10.6% and 10%. The ranking below is a fundamentals filter on margin, dilution and balance sheet; the filing is the thesis.
3. For the deployed fleets, the bottleneck is utilization, not hardware. Both service-robot names here grew revenue strongly in the June quarter, and the growth is not the number that matters. Serve Robotics has more than 2,000 Gen 3 robots deployed but averaged 792 daily active robots in Q2 2026 — roughly 40% of the fleet earning on a given day — and cut its full-year 2026 revenue guidance by more than half because the Uber Eats partnership routed fewer orders than planned. Richtech Robotics reported fiscal third-quarter revenue of $1.37 million while holding $339.6 million of cash and short-term investments against a $0.41 billion market cap, so the stock trades at roughly the value of its cash pile.
The bear case starts with the calendar. Goldman's ramp runs from about 75,000 humanoid units in 2026 to 890,000 in 2030, so the volumes that would move a lidar or actuator supplier's income statement are years out, and until then each supplier here is priced on its non-robot business. Ouster at roughly 12x sales already prices in sustained growth, so a single quarter below the guided range, or price pressure from Chinese lidar makers, would compress the multiple faster than fundamentals could recover. Proto Labs trades back to a cyclical manufacturing multiple if industrial capex softens, and as humanoid programs reach volume production the work migrates to high-volume contract manufacturers. Allient is an industrial motion supplier with $173.3 million of debt and a vehicle segment that shrank 7%. The fleets carry their own problems: Richtech's financial statements were restated in August, and Serve's quarterly net loss against its cash makes another equity raise likely before utilization proves out.
The Names
OUST — Ouster, Inc.
Score: 60.3 (SOLID) | Market cap: $2.45B | Revenue YoY: +52.5% | Rule of 40: 8.8 | Cash runway: 20 months
Ouster builds digital lidar and camera sensors for industrial, robotics, automotive and smart-infrastructure customers. Second-quarter 2026 revenue was $54.6 million, up 56% year over year and 12% sequentially, the 14th straight quarter of growth; the company shipped more than 17,000 sensors, about 53% of them lidar, against roughly 5,500 a year earlier, and GAAP gross margin rose to 49% from 45%. The SOLID score rests on the +52.5% trailing growth input and a positive Rule of 40, while a P/S ratio near 12 and 20% twelve-month dilution hold it back. The 20-month runway input is computed from historical burn and understates the $263 million of cash, restricted cash and short-term investments at June 30, 2026 against an $18.1 million quarterly net loss. At $2.45 billion it is the largest name here and has outgrown the sub-$2 billion definition on the live tape. The catalyst is execution against the $54.5 to $57.5 million third-quarter revenue guide as the Rev8 generation ramps.
PRLB — Proto Labs, Inc.
Score: 59.4 (SPECULATIVE) | Market cap: $1.88B | Revenue YoY: +6.4% | Rule of 40: 11.4 | Cash runway: net cash
Proto Labs is the digital manufacturer robot developers use when they need a gripper, sensor housing, gear or motor mount in days rather than months — CNC machining, injection molding, 3D printing and sheet metal. In September 2026 it disclosed that revenue from its robotics customers more than doubled in the first half of 2026, and it is exhibiting at RoboBusiness on October 20 to 21. Second-quarter 2026 revenue was a record $149.3 million, up 10.6%, with GAAP gross margin of 46.4% and adjusted EPS of $0.60 versus $0.41; full-year 2026 revenue growth guidance was raised to 8% to 10% from 6% to 8%. The balance sheet is net cash — $162.9 million of cash and investments, debt-to-equity below 1% in the scan — so the SPECULATIVE score is capped only by the modest +6.4% trailing growth input and a 3.4x P/S. Robotics remains an undisclosed-size slice of a business that mainly serves industrial, medical and aerospace prototyping; the catalyst is the third-quarter report against the raised guide and any further robotics-mix disclosure.
ALNT — Allient Inc.
Score: 57.5 (SPECULATIVE) | Market cap: $1.48B | Revenue YoY: +4.6% | Rule of 40: 13.3 | Cash runway: n/a (operating cash flow positive)
Allient makes precision motors, servo drives, motion controllers and power-quality equipment, and it markets advanced actuation systems for humanoid robotics directly — the actuator layer of this list. Second-quarter 2026 revenue was $153.8 million, up 10%, with a record 34.9% gross margin, a 10.2% operating margin and net income of $10.4 million, up 85%. Orders hit a record $201.3 million, up 49%, for a $298 million backlog that management expects to convert over 3 to 9 months; data center revenue of $16.3 million grew 60%. The SPECULATIVE score reflects the stale +4.6% trailing growth input and a 67% debt-to-equity ratio, not the Q2 acceleration. The runway row's n/a means operating cash flow is positive, which is not the same as a debt-free balance sheet: Allient carried $173.3 million of total debt against about $42 million of cash. Humanoid robotics is not yet a disclosed revenue line. The catalyst is backlog conversion in the third-quarter report in November; the live market cap has already run 33% above the snapshot.
RR — Richtech Robotics Inc.
Score: 44.2 (SPECULATIVE) | Market cap: $0.41B | Revenue YoY: +19.0% | Rule of 40: -321.9 | Cash runway: 250 months
Richtech Robotics is the closest thing in our universe to a humanoid-form commercial robot: ADAM, its humanoid service robot, works as a barista in Times Square, and Dex, a mobile humanoid, debuted at CES 2026. The business behind the demos is tiny: fiscal third-quarter revenue was $1.37 million, with robotics-as-a-service revenue up more than 200%. The list case is the balance sheet: $301.96 million of cash plus $37.63 million of short-term investments at June 30, 2026, against $4.1 million of total liabilities and no debt, raised through at-the-market sales and a private placement. Hence the 61% twelve-month dilution input and the 76x P/S drag the score to SPECULATIVE while the 250-month runway reflects a cash pile covering most of the market cap. In August 2026 management announced a buyback of up to $12 million and restated the financial statements from September 30, 2024 through December 31, 2025, so the cash-backed thesis depends on controls that have already failed once. The real catalyst, a disclosed commercialization timeline or pricing for Dex, does not yet exist.
SERV — Serve Robotics Inc.
Score: 40.1 (SPECULATIVE) | Market cap: $0.41B | Revenue YoY: +46.2% | Rule of 40: -4207.6 | Cash runway: 16 months
Serve Robotics operates sidewalk delivery robots — more than 2,000 Gen 3 units deployed across US cities for DoorDash and Uber Eats plus healthcare and grocery customers. Second-quarter 2026 revenue was $3.2 million, up 404% year over year, and recurring revenue exceeded 50% of the mix. The number that matters is 792: average daily active robots, down from 812 in the first quarter. The company cut full-year 2026 revenue guidance to $9 million to $10 million from $26 million, citing lower-than-expected Uber Eats delivery volume, even as DoorDash revenue grew nearly 50% sequentially. The SPECULATIVE score is doing its job: the -580% trailing gross margin, the -4,208 Rule of 40, 53x sales and 28% dilution describe a fleet that is built but under-utilized. The quarter's net loss was $64.1 million against $240.4 million of cash and marketable securities at June 30, 2026, so the 16-month runway input is realistic. The catalyst is utilization, not deployment: daily active robots climbing toward the deployed fleet via a second volume partner.
How to Think About Position Sizing
Three tiers, defined by visible robotics revenue and the balance sheet underneath it.
Perception growth at a growth multiple (OUST). A long run of consecutive growth quarters and cash well in excess of the quarterly loss, bought at a double-digit sales multiple with equity issuance behind it. A single quarter below the guided range compresses that multiple faster than fundamentals recover, so size the position to the guide, not to the Goldman forecast.
Profitable suppliers (PRLB, ALNT). Both grew June-quarter revenue by 10% or more and both earn money — Proto Labs on adjusted EPS, Allient on net income. The difference is the balance sheet and the disclosure: Proto Labs is net cash and has already disclosed its robotics growth, while Allient carries more debt than cash, has not quantified a humanoid program, and already trades well above its snapshot market cap. Weight Proto Labs ahead of Allient, and treat Allient's backlog conversion in November as the thing to check.
Deployed fleets with unresolved economics (RR, SERV). Richtech is cash-backed, but the statements behind that cash were restated in August and the business lost roughly $10 million in the June quarter, most of it a $9.47 million software impairment, on revenue in the low single-digit millions. Serve is the opposite shape: fast revenue growth, a heavy quarterly loss, a short runway input and guidance cut by more than half. Both are options on utilization; neither should be sized like a supplier.
A practical mix: roughly 30% in Ouster; 50% in the two suppliers, tilted toward Proto Labs; 20% split across Richtech and Serve, small enough that a restatement or an equity raise is survivable.
How We Scored
Our model rates 2,200+ US small-cap stocks (market cap <$2B) across eight fundamentals: revenue growth, gross margin, cash runway, debt/equity, P/S ratio, Rule of 40, insider ownership and 12-month dilution, sector-adjusted where appropriate. Scores are refreshed regularly; this list uses the September 27, 2026 snapshot, and each write-up flags where the trailing growth input has been overtaken by the June-quarter filing. See the methodology and track record or browse the screener for small-cap industrial and small-cap technology stocks.
Related Coverage
- 6 Best Small-Cap Humanoid & Service Robotics Stocks — June 2026
- 8 Best Small-Cap Edge AI Semiconductor Stocks — October 2026
- 4 Best Small-Cap Surgical Robotics & Med-Device Stocks — May 2026
- Small-Cap Robotics Stocks April 2026 — Only 3 Pass Our Filter
Data as of September 27, 2026. Updated monthly. Past performance does not guarantee future results. Not investment advice.